TY - JOUR
T1 - The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease
T2 - a multicentre, randomised controlled trial
AU - Osadnik, Christian
AU - McDonald, Christine F
AU - Miller, Belinda
AU - Hill, Catherine
AU - Tarrant, Ben
AU - Steward, Ranjana
AU - Chao, Caroline
AU - Stodden, Nicole
AU - Oliveira, Cristino C
AU - Gagliardi, Nadia
AU - Holland, Anne E
PY - 2014
Y1 - 2014
N2 - Positive expiratory pressure (PEP) is a technique used to enhance sputum clearance during acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The impact of PEP therapy during acute exacerbations on clinically important outcomes is not clear. This study sought to determine the effect of PEP therapy on symptoms, quality of life and future exacerbations in patients with AECOPD.
AB - Positive expiratory pressure (PEP) is a technique used to enhance sputum clearance during acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The impact of PEP therapy during acute exacerbations on clinically important outcomes is not clear. This study sought to determine the effect of PEP therapy on symptoms, quality of life and future exacerbations in patients with AECOPD.
UR - http://thorax.bmj.com/content/69/2/137.full.pdf+html
U2 - 10.1136/thoraxjnl-2013-203425
DO - 10.1136/thoraxjnl-2013-203425
M3 - Article
VL - 69
SP - 137
EP - 143
JO - Thorax
JF - Thorax
SN - 0040-6376
IS - 2
ER -